Publications by authors named "LinSen Ye"

Claim this Profile
M
Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma.
Yongwei Hu, Kaiming He, Mingshen Zhang, Li Wang, Lei Lyu, Linsen Ye

Biomaterials· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FXR-mediated antigen-specific CD8 T cell enhances antitumor immunity in intrahepatic cholangiocarcinoma.
Shanshan Liu, Zhixing Liang, Lisi Zhu, Yuhao Zheng, Haoyuan Yu, Shusen Ye, Lilin Ye, Linsen Ye

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion.
Haoyuan Yu, Mengchen Shi, Xuejiao Li, Zhixing Liang, Kun Li, Linsen Ye

Chin Med J (Engl)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactate accumulation drives hepatocellular carcinoma metastasis through facilitating tumor-derived exosome biogenesis by Rab7A lactylation.
Chenhao Jiang, Xinyi He, Xialin Chen, Jianyang Huang, Yasong Liu, Linsen Ye, Jianye Cai

Cancer Lett· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies.
Yutao Chen, Desheng Chen, Zhixing Liang, Haoyuan Yu, Haobin Sun, Linsen Ye

Cancer Drug Resist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FXR inhibition functions as a checkpoint blockade of the pathogenic Tfh cell response in lupus.
Xiangyang Wang, Linsen Ye, Shanshan Liu, Yuhao Zheng, Lisi Zhu, Lilin Ye

Cell Mol Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
METTL3 knockout accelerates hepatocarcinogenesis via inhibiting endoplasmic reticulum stress response.
Bo Cui, Silin Tu, Haibo Li, Zhancheng Zeng, Ruiqi Xiao, Linsen Ye

FEBS Open Bio· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explainable machine learning for the assessment of donor grafts in liver transplantation.
Liang Zhixing, Ye Linsen, Jiang Peng, Dong Siyi, Yu Haoyuan

Hepatol Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research landscape and trends of human umbilical cord mesenchymal stem cell-derived exosomes.
Desheng Chen, Zeping Chen, Jiabin Yuan, Guanzi Chen, Yutao Chen, Linsen Ye

Stem Cell Res Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor derived exosomal ENTPD2 impair CD8 T cell function in colon cancer through ATP-adenosine metabolism reprogramming.
Mengchen Shi, Linsen Ye, Lu Zhao, Lingyuan He, Junxiong Chen

Cell Commun Signal· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cold-induced FOXO1 nuclear transport aids cold survival and tissue storage.
Xiaomei Zhang, Lihao Ge, Guanghui Jin, Yasong Liu, Qingfen Yu, Linsen Ye

Nat Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic network biomarker C1QTNF1 regulates tumor formation at the tipping point of hepatocellular carcinoma.
Haoyuan Yu, Xijing Yan, Guanxing Chen, Rong Li, Zhou Yang, Linsen Ye

Biomol Biomed· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of surface CD51 and γ-secretase-mediated CD51 cleavage improves therapeutic efficacy in experimental metastatic hepatocellular carcinoma.
Jianye Cai, Jiancheng Wang, Chenhao Jiang, Linsen Ye, Xinyi He

J Hepatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8 exhausted-like T cells.
Siqi Li, Kun Li, Kang Wang, Haoyuan Yu, Xiangyang Wang, Linsen Ye

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study.
Rongqiang Liu, Shinan Wu, Hao Yuan Yu, Kaining Zeng, Zhixing Liang, Linsen Ye

Heliyon· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to 'Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC' by Yang .
Kun Li, Yunfei Qin, Linsen Ye

J Immunother Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy.
Si-Qi Li, Yang Yang, Lin-Sen Ye

World J Gastroenterol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma.
Tianxing Dai, Linsen Ye, Mingbin Deng, Guozhen Lin, Rongqiang Liu

J Clin Transl Hepatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
Kun Li, Yihang Gong, Dongbo Qiu, Hui Tang, Jian Zhang, Linsen Ye

J Immunother Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma: A single-arm, multicenter, prospective study.
Ren-Yi Su, Sun-Bin Ling, Qiao-Nan Shan, Xu-Yong Wei, Rui Wang, Lin-Sen Ye, Shao-Jun Ye, Qi-Fa Ye

Hepatobiliary Pancreat Dis Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma.
Tianxing Dai, Jing Li, Linsen Ye, Haoyuan Yu, Mingbin Deng

J Clin Transl Hepatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NTF3 Correlates With Prognosis and Immune Infiltration in Hepatocellular Carcinoma.
Rongqiang Liu, Rongqi Li, Haoyuan Yu, Jianrong Liu, Shiyang Zheng, Linsen Ye

Front Med (Lausanne)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma.
Yihang Gong, Kun Li, Yunfei Qin, Kaining Zeng, Jianrong Liu, Yewu Chen, Linsen Ye

Front Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma.
Rongqiang Liu, Weihao Kong, ZeKun Jiang, Shiyang Zheng, Xiaofeng Yuan, Linsen Ye

J Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma.
Tianxing Dai, Linsen Ye, Haoyuan Yu, Kun Li, Jing Li

J Hepatocell Carcinoma· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis